News and Trends 19 Dec 2017 Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim signing collaborations with Autifony and Evox Therapeutics. In the last… December 19, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 2 May 2023 Single-molecule valve breakthrough could lead to early disease diagnosis …help with detecting very small amounts of pathogens for early diagnosis of diseases such as cancers and Parkinson’s disease, without requiring expensive equipment.” The findings of this study could be… May 2, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 GATC AI platform reduces time to find opioid use disorder candidates …of medicine.” With the platform’s new drug discovery, GATC has the potential to improve other treatments such as addiction, post-traumatic stress disorder (PTSD), Alzheimer’s disease, Parkinson’s disease, major depressive disorder… October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2016 Proteins can now Sing about their Anomalies to help cure Diseases …degenerative diseases like Alzheimer’s and Parkinson’s. Sonification could also be applied to gene sequences to identify targets for CRISPR therapies and cure genetic disease. Beyond all of these potential uses,… October 26, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 14 Apr 2025 Metabolomics: The study of biology’s dark matter …die on the vine because they didn’t hit their clinical readout. Metabolomics can help as a diagnostic tool in fields where the readout is just not as rich, like Parkinson’s… April 14, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jul 2018 Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial …other diagnostics for neurodegenerative diseases. The company is partnering with Eisai and AbbVie on projects for Alzheimer’s and Parkinson’s disease, respectively. BioArctic’s stock price increased by a staggering 400% three… July 9, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
More News! 9 Nov 2017 Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease …disease proteins. Using this technology, the company has built a pipeline of promising candidates against neurodegenerative diseases like Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS). Last year, the Swiss biotech… November 9, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Mar 2025 These 7 biotechs are shaping the next generation of endometriosis care …company Kissei Pharmaceutical has drug candidates in its pipeline to address different kinds of diseases, including Parkinson’s disease and non-muscle-invasive bladder cancer. But the biotech company’s most advanced drug in… March 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jan 2025 A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development …small molecule candidate to treat people with Parkinson’s disease. Vesalius was founded by the life sciences venture capital Flagship Pioneering. The startup incubator and GSK pooled in $150 million in… January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2018 Update: Forbion’s Life Science Fund Tops Goal by €90M …in its portfolio, working in Parkinson’s, was acquired by Lundbeck in a deal that could reach near €1Bn. Other successes have been the €464M acquisition of Rigontec and a smaller… October 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 May 2017 Danish Biotech Targeting Ion Channels Completes Private Placement …wide range of conditions, such as obesity, type 2 diabetes, cocaine addiction, Parkinson’s, and schizophrenia, the latter being researched in collaboration with Boehringer Ingelheim. Cover image via TJmedia /Shutterstock … May 17, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 …as C9orf72 in ALS and frontotemporal dementia. As of now, its ALS treatment is in the discovery phase, along with two other programs focused on Parkinson’s and Alzheimer’s. As its… January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email